Market Research Industry Reports

United States Interventional Cardiology Market Outlook to 2025

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
United States Interventional Cardiology Market Outlook to 2025

Summary

GlobalDatas new report, United States Interventional Cardiology Market Outlook to 2025, provides key market data on the United States Interventional Cardiology market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments -Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Interventional Cardiology market segments - Arteriotomy Closure Devices, Cardiac Catheters, Coronary Guidewires, Coronary Stents, Intravascular Ultrasound Systems (IVUS), PTCA Balloons Catheters and PTCA Drug Eluting Balloon (DEB) Catheters.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2015 to 2025.
- 2017 company share and distribution share data for Interventional Cardiology market.
- Global corporate-level profiles of key companies operating within the United States Interventional Cardiology market.
- Key players covered include Abbott Laboratories, Boston Scientific Corp, Medtronic plc, and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.
2 Introduction 8
2.1 What Is This Report About? 8
2.2 Interventional Cardiology Market Segmentation 8
2.3 Definitions of Markets Covered in the Report 9
3 Interventional Cardiology Market, United States 13
3.1 Interventional Cardiology Market, United States, Revenue ($m), 2015-2025 13
3.1.1 Arteriotomy Closure Devices Market, United States, Revenue ($m), by Segment, 2015-2025 16
3.1.2 Cardiac Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 18
3.1.3 Coronary Stents Market, United States, Revenue ($m), by Segment, 2015-2025 20
3.1.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), by Segment, 2015-2025 23
3.1.5 PTCA Balloons Catheters Market, United States, Revenue ($m), by Segment, 2015-2025 25
3.2 Interventional Cardiology Market, United States, Volume (Units), 2015-2025 27
3.2.1 Arteriotomy Closure Devices Market, United States, Volume (Units), by Segment, 2015-2025 30
3.2.2 Cardiac Catheters Market, United States, Volume (Units), by Segment, 2015-2025 32
3.2.3 Coronary Stents Market, United States, Volume (Units), by Segment, 2015-2025 34
3.2.4 Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), by Segment, 2015-2025 37
3.2.5 PTCA Balloons Catheters Market, United States, Volume (Units), by Segment, 2015-2025 39
3.3 Interventional Cardiology Market, United States, Average Price ($), 2015-2025 41
3.4 Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), 2017 45
3.5 Interventional Cardiology Market, United States, Company Share by Revenue ($m), 2017 46
4 Overview of Key Companies in United States, Interventional Cardiology Market 48
4.1 Abbott Laboratories 48
4.1.1 Company Overview 48
4.2 Terumo Corp 48
4.2.1 Company Overview 48
4.3 Boston Scientific Corp 48
4.3.1 Company Overview 48
4.4 Medtronic Plc 48
4.4.1 Company Overview 48
4.5 Cook Medical Inc 49
4.5.1 Company Overview 49
4.6 Asahi Kasei Corp 49
4.6.1 Company Overview 49
4.7 Philips Healthcare 49
4.7.1 Company Overview 49
4.8 Cardinal Health Inc 49
4.8.1 Company Overview 49
5 Interventional Cardiology Market Pipeline Products 50
6 Financial Deals Landscape 51
6.1 Acquisition 51
6.1.1 BTG Acquires Roxwood Medical 51
6.1.2 Royal Philips Acquires Spectranetics 52
6.2 Debt Offerings 54
6.2.1 Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 54
6.3 Equity Offerings 56
6.3.1 Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 56
6.3.2 Osprey Medical Raises USD8.2 Million in Rights Offering of CDIs 58
6.3.3 Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares 60
6.3.4 Corindus Vascular Robotics Plans to Raise up to USD81.7 Million in Secondary Offering of Shares 62
6.3.5 AngioDynamics Prices Public Offering of Shares for USD38 Million 63
6.4 Partnerships 65
6.4.1 Corindus Vascular Robotics Enters into Partnership with BLOXR 65
6.5 Venture Financing 66
6.5.1 Cardiva Medical Raises Additional USD11 Million in Venture Financing 66
6.5.2 Shockwave Medical Raises Additional USD35 Million in Series C Financing 68
6.5.3 Saphena Medical Raises USD2.7 Million in Venture Financing 69
7 Recent Developments 70
7.1 Corporate Communications 70
7.1.1 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 70
7.1.2 Feb 27, 2018: Z-Medica Announces Appointment Of Eric Compton As CEO 70
7.1.3 Feb 21, 2018: Endologix Announces Resignation Of John McDermott As Chief Executive Officer 70
7.1.4 Feb 20, 2018: AtriCure Names Scott Drake Board Chairman 71
7.1.5 Feb 12, 2018: Integer Elects James Hinrichs to its Board of Directors 71
7.1.6 Feb 02, 2018: Cardiovascular Systems Appoints Jeff Points as Chief Financial Officer 72
7.1.7 Jan 29, 2018: Endologix Names Greg Morrow As Chief Marketing Officer 72
7.1.8 Jan 29, 2018: Endologix Appoints Greg Morrow as Chief Marketing Officer 73
7.1.9 Jan 24, 2018: Cardiovascular Systems Appoints Rhonda Robb as New Chief Operating Officer 73
7.1.10 Jan 03, 2018: Tryton Medical Announces New CEO and President 74
7.1.11 Jan 02, 2018: Integer Names Kirk Thor Chief Human Resources Officer 74
7.1.12 Nov 22, 2017: IMRIS Appoints Mark Strong as Senior Vice President - Research & Development 74
7.1.13 Nov 20, 2017: Follicum applies for the start of a Phase II study at the German Medicines Agency 75
7.1.14 Oct 31, 2017: Luminex Corporation Receives FDA Clearance for ARIES Group A Strep Assay 75
7.1.15 Oct 19, 2017: Endologix Appoints John Onopchenko as Chief Operating Officer 77
7.1.16 Oct 04, 2017: Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary 77
7.1.17 Oct 02, 2017: Jeffrey H. Burbank Joins CryoLife Board of Directors 78
7.1.18 Sep 26, 2017: Edward Parent Appointed Director of Quality Assurance at TissueGen 78
7.1.19 Aug 28, 2017: Abiomed Announces Resignation of Chief Financial Officer and Welcomes Back Former Chief Financial Officer as Consultant 79
7.1.20 Aug 08, 2017: John K. Bakewell Joins Corindus Vascular Robotics Board of Directors 79
7.1.21 Jul 31, 2017: Atara Biotherapeutics Announces Two Presentations at MSParis2017, Including Updated, Interim Results from a Phase 1 Study of Autologous ATA188 in Patients with Progressive Multiple Sclerosis 80
7.1.22 Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer 81
7.1.23 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 81
7.1.24 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants Joins Osprey Board 82
7.1.25 Jun 20, 2017: Medtronic VP and GM Sandra Lesenfants J oins Osprey Board 82
7.1.26 Jun 14, 2017: Spectranetics Announces Election of New Chairperson of the Board of Directors 83
7.1.27 May 26, 2017: Merit Medical Announces Appointment of New Director 83
7.1.28 Apr 19, 2017: TissueGen appoints New Faces for Growing Sales Team 83
7.2 Financial Announcements 84
7.2.1 Mar 14, 2018: Corindus Reports Fourth Quarter and Full Year 2017 Results 84
7.2.2 Mar 07, 2018: CryoLife Reports Fourth Quarter and Full Year 2017 Results 84
7.2.3 Feb 26, 2018: AtriCure Announces Fourth Quarter and Full Year 2017 Financial Results 85
7.2.4 Feb 22, 2018: Integer Holdings Reports Results for Fourth Quarter and Full Year 2017 86
7.2.5 Feb 21, 2018: Endologix Reports Fourth Quarter and Fiscal Year 2017 Financial Results 87
7.2.6 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 88
7.2.7 Feb 08, 2018: Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance 89
7.2.8 Feb 07, 2018: Cardiovascular Systems Reports Fiscal 2018 Second-Quarter Financial Results 89
7.2.9 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 90
7.2.10 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 92
7.2.11 Jan 23, 2018: Glytecs Software Yields Superior Patient Outcomes According to Four New Studies in Journal of Diabetes Science and Technology 92
7.2.12 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 94
7.2.13 Jan 08, 2018: AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2017 94
7.2.14 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 95
7.2.15 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 95
7.2.16 Dec 12, 2017: Cyclacel Announces Presentation of Results From Phase 3 Seamless Study at Ash Annual Meeting 96
7.2.17 Nov 08, 2017: Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance 97
7.2.18 Nov 07, 2017: Endologix Reports Third Quarter 2017 Financial Results 98
7.2.19 Nov 07, 2017: Corindus Vascular Robotics Reports Third Quarter 2017 Results 99
7.2.20 Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results 99
7.2.21 Oct 31, 2017: Abbott Announces FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems 100
7.2.22 Oct 31, 2017: Northwell expands technology that precisely targets breast tumors 102
7.2.23 Oct 30, 2017: CryoLife Reports Third Quarter 2017 Results 104
7.2.24 Oct 26, 2017: Abiomed Announces Q2 FY 2018 Revenue of $132.8 Million, Up 29% and Record U.S. Patient Utilization, Up 33% 106
7.2.25 Oct 26, 2017: Boston Scientific Announces Results For Third Quarter 2017 106
7.2.26 Oct 26, 2017: Integer Holdings Reports Third Quarter 2017 Results 108
7.2.27 Oct 25, 2017: Cardiovascular Systems Reports Fiscal 2018 First-Quarter Financial Results 109
7.2.28 Oct 25, 2017: Merit Medical Reports Results for Third Quarter 2017 110
7.2.29 Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results 111
7.2.30 Aug 15, 2017: CareRay Exhibits At FIME 2017 112
7.2.31 Aug 08, 2017: Corindus Vascular Robotics Reports Second Quarter 2017 Results 113
7.2.32 Aug 03, 2017: Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance 113
7.2.33 Aug 03, 2017: Spectranetics Reports Second Quarter 2017 Revenue of $74.7 million 114
7.2.34 Aug 02, 2017: Cardiovascular Systems Reports Fiscal 2017 Fourth-Quarter Financial Results 114
7.2.35 Aug 02, 2017: Endologix Reports Second Quarter 2017 Financial Results 116
7.2.36 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 116
7.2.37 Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results 118
7.2.38 Jul 27, 2017: Abiomed Announces Q1 FY 2018 Revenue of $132.5 Million, Up 29% Over Prior Year 118
7.2.39 Jul 27, 2017: Integer Holdings Reports Second Quarter 2017 Results 119
7.2.40 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 120
7.2.41 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 121
7.2.42 Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results 122
7.2.43 May 09, 2017: Corindus Vascular Robotics Reports First Quarter 2017 Results 124
7.2.44 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 125
7.2.45 May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results 125
7.2.46 May 04, 2017: Abiomed Announces Q4 FY 2017 Revenue of $124.7 Million, Up 33% Over Prior Year and Total Year Revenue of $445.3 Million, Up 35% Over Prior Year 126
7.2.47 May 04, 2017: Endologix Reports First Quarter 2017 Financial Results 127
7.2.48 May 03, 2017: Cardiovascular Systems Reports Fiscal 2017 Third-Quarter Financial Results 128
7.2.49 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 129
7.2.50 Apr 27, 2017: Surmodics Reports Second Quarter Fiscal 2017 Results, Updates Fiscal 2017 Financial Guidance 130
7.2.51 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 131
7.2.52 Apr 27, 2017: Spectranetics Reports First Quarter 2017 Revenue of $69.7 million 131
7.2.53 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 132
7.2.54 Apr 20, 2017: bioMerieux: The FilmArray Respiratory Panel 2 plus (RP2plus) Gets CE Marked 132
7.2.55 Apr 17, 2017: Lixte Biotechnologys Protein Phosphatase 2A Inhibitor, LB-100, Reported to be a Potentiator of Immunotherapy in an Animal Model 135
7.2.56 Apr 17, 2017: Surmodics Appoints Lisa Wipperman Heine to Its Board of Directors 135
7.3 Government and Public Interest 136
7.3.1 Jul 19, 2017: NIDEKs Me1200 won the "Ponts dOr" award in France 136
7.4 Legal And Regulatory 137
7.4.1 Mar 13, 2018: Precipio Settles Lawsuit with Crede Capital 137
7.4.2 Nov 03, 2017: Neovasc Provides Litigation Update 137
7.4.3 Oct 18, 2017: Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset 138
7.4.4 Sep 07, 2017: Ignyta To Host Conference Call And Live Webcast On September 11 To Provide Pipeline Review, Including Lead Candidate Entrectinib 138
7.5 Other Significant Developments 139
7.5.1 Feb 22, 2018: Integer Announces Strategy Focused on Portfolio Management and Operational Excellence; Aligns Senior Management to Execute Strategic Imperatives 139
7.5.2 Feb 08, 2018: IMRIS Reports Continued Strong Growth in 2017 140
7.5.3 Sep 18, 2017: Cardiovascular Systems Announces Anticipated Revenue Impact from Hurricanes Harvey and Irma 140
7.5.4 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 141
7.5.5 Apr 25, 2017: AtriCures AtriClip System Surpasses 100,000 Units Sold Worldwide 142
7.6 Product News 143
7.6.1 Jan 02, 2018: Corindus to Participate with Mayo Clinic in Preclinical Study of Remote Control Robotics for Percutaneous Coronary Interventions Remote Treatment Capabilities 143
7.6.2 Oct 10, 2017: Allergan Announces that the FDA Accepts New Drug Application for Ulipristal Acetate for Uterine Fibroids 143
7.7 Strategy And Business Planning 144
7.7.1 Sep 26, 2017: MicroVention Celebrates Grand Opening of New Worldwide Innovation Center in Aliso Viejo, California 144
8 Appendix 146
8.1 Research Methodology 147
8.1.1 Coverage 147
8.1.2 Secondary Research 147
8.1.3 Primary Research 148
8.1.4 Market Modeling and Forecasting 149
8.1.5 Company Share Analysis 150
8.1.6 Distribution Share Analysis 151
8.1.7 Benchmarking 151
8.2 GlobalData Consulting 151
8.3 Contact Us 152
8.4 Disclaimer 152

List Of Tables

1.1 List of Tables
Table 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2020 14
Table 2: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2021-2025 15
Table 3: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2020 17
Table 4: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2021-2025 17
Table 5: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 19
Table 6: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 19
Table 7: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2020 21
Table 8: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2021-2025 22
Table 9: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2020 24
Table 10: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2021-2025 24
Table 11: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2020 26
Table 12: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2021-2025 26
Table 13: Interventional Cardiology Market, United States, Volume (Units), 2015-2020 28
Table 14: Interventional Cardiology Market, United States, Volume (Units), 2021-2025 29
Table 15: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2020 31
Table 16: Arteriotomy Closure Devices Market, United States, Volume (Units), 2021-2025 31
Table 17: Cardiac Catheters Market, United States, Volume (Units), 2015-2020 33
Table 18: Cardiac Catheters Market, United States, Volume (Units), 2021-2025 33
Table 19: Coronary Stents Market, United States, Volume (Units), 2015-2020 35
Table 20: Coronary Stents Market, United States, Volume (Units), 2021-2025 36
Table 21: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2020 38
Table 22: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2021-2025 38
Table 23: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2020 40
Table 24: PTCA Balloons Catheters Market, United States, Volume (Units), 2021-2025 40
Table 25: Interventional Cardiology Market, United States, Average Price ($), 2015-2020 41
Table 26: Interventional Cardiology Market, United States, Average Price ($), 2021-2025 43
Table 27: Interventional Cardiology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 45
Table 28: Interventional Cardiology Market, United States, Company Share by Revenue ($m), USD Constant, 2017 47
Table 29: Interventional Cardiology Market Pipeline Products 50
Table 30: BTG Acquires Roxwood Medical 51
Table 31: Royal Philips Acquires Spectranetics 52
Table 32: Boston Scientific Raises USD1 Billion in Public Offering of 4% Notes Due 2028 54
Table 33: Corindus Vascular Robotics to Raise USD25 Million in Private Placement of Preferred Shares and Warrants 56
Table 34: Osprey Medical Raises USD8.2 Million in Rights Offering of CDIs 58
Table 35: Endologix Plans to Raise USD46.2 Million in Equity Offering of Shares 60
Table 36: Corindus Vascular Robotics Plans to Raise up to USD81.7 Million in Secondary Offering of Shares 62
Table 37: AngioDynamics Prices Public Offering of Shares for USD38 Million 63
Table 38: Corindus Vascular Robotics Enters into Partnership with BLOXR 65
Table 39: Cardiva Medical Raises Additional USD11 Million in Venture Financing 66
Table 40: Shockwave Medical Raises Additional USD35 Million in Series C Financing 68
Table 41: Saphena Medical Raises USD2.7 Million in Venture Financing 69
Table 42: Total Number of Primary Research Participants, Cardiovascular Devices Market, by Country 149

List Of Figures

1.2 List of Figures
Figure 1: Interventional Cardiology Market, United States, Revenue ($m), USD Constant, 2015-2025 13
Figure 2: Arteriotomy Closure Devices Market, United States, Revenue ($m), USD Constant, 2015-2025 16
Figure 3: Cardiac Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 18
Figure 4: Coronary Stents Market, United States, Revenue ($m), USD Constant, 2015-2025 20
Figure 5: Intravascular Ultrasound Systems (IVUS) Market, United States, Revenue ($m), USD Constant, 2015-2025 23
Figure 6: PTCA Balloons Catheters Market, United States, Revenue ($m), USD Constant, 2015-2025 25
Figure 7: Interventional Cardiology Market, United States, Volume (Units), 2015-2025 27
Figure 8: Arteriotomy Closure Devices Market, United States, Volume (Units), 2015-2025 30
Figure 9: Cardiac Catheters Market, United States, Volume (Units), 2015-2025 32
Figure 10: Coronary Stents Market, United States, Volume (Units), 2015-2025 34
Figure 11: Intravascular Ultrasound Systems (IVUS) Market, United States, Volume (Units), 2015-2025 37
Figure 12: PTCA Balloons Catheters Market, United States, Volume (Units), 2015-2025 39
Figure 13: Interventional Cardiology Market, United States, Company Share (%) 2017 46

2018 United Arab Emirates Nucleic Acid Testing (NAT) Market: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.Highlights- Five-year test

USD 4250View Report

2018 United Arab Emirates Virology and Bacteriology Testing Market: Supplier Shares and Strategies, Test Volume and Sales Forecasts, Technology and Instrumentation Review

This new report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the infectious disease testing market during the next five years.

USD 4500View Report

United States Cardiovascular Devices Market Outlook to 2025 - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology and Others

United States Cardiovascular Devices Market Outlook to 2025 - Cardiac Assist Devices, Cardiac Rhythm Management Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery Devices, Electrophysiology Devices, External Defibrillators, Interventional Cardiology and OthersGlobalDatas

USD 5995View Report

Real Estate in the United States

Real Estate in the United StatesReal Estate in the United States industry profile provides top-line qualitative and quantitative information including: market size (value and volume 2013-17, and forecast to

USD 350View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 4995
  • Site Licence    USD 9990
  • Enterprise Wide Licence    USD 14985
$ 4995

Reports Details

Published Date : Apr 2018
No. of Pages :152
Country :United States of America
Category :Medical Devices
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube